跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEXMEDETOMIDINA KABI 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DEXMEDETOMIDINA KABI 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Approved
STANDARD
DEXMEDETOMIDINA KABI 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Fresenius Kabi España, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 20, 2022
Approval ID
bdc5bdbc08d28271
Company
Fresenius Kabi España, S.A.U.
Type
Standard
Approval Details
Approval Id
bdc5bdbc08d28271
Drug Cima Aemps Name
DEXMEDETOMIDINA KABI 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number
86566
Holder Company Name
Fresenius Kabi España, S.A.U.
Marketing Company Name
Fresenius Kabi España, S.A.U.
Authorization Date
2022-02-20
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
100 microgramos/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Fresenius Kabi España, S.A.U.
Active Ingredients
DEXMEDETOMIDINA HIDROCLORURO
0,118 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 20, 2022
Approval ID
bdc5bdbc08d28271
Type
Standard
Back to CIMA-AEMPS Approvals